Saxagliptin and metformin hydrochloride extended-release tablets are contraindicated in patients with an eGFR below 30 mL/minute/1.73 m2
And they work, for some people
Side effects and safety As semaglutide and dulaglutide have the same mechanism of action, they have similar side effects and safety profiles
With Tirzepatide (Zepbound) now having FDA approval for obesity, rumblings have again started about whether there will be increased price pressure and perhaps a reduction in cost for GLP-1s, which could bring increased access
Due to the therapeutic implications of biased agonism and differential efficacy, understanding the molecular details of how different peptides engage and activate the GLP-1R is crucial
Injection site reactions like redness, itching, or small lumps occasionally occur